Cardinal Health, Inc. CAH
278.32 USD -0.93 (-0.33%)
Regular-session close
278.32 0.00 0.00%
After hours · Nov 18, 5:28 PM ET
275.94 Day range 280.21
180.45 52-week range 286.29
- YTD
- +35.44%
- 1 year
- +34.47%
News
benzinga.com Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $320 Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $275 to $320.
zacks.com Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.benzinga.com Wells Fargo Maintains Overweight on Cardinal Health, Raises Price Target to $321 Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $277 to $321.
defenseworld.net Banco Santander S.A. Purchases 12,420 Shares of Cardinal Health, Inc. $CAH Banco Santander S.A. boosted its position in shares of Cardinal Health, Inc. (NYSE: CAH) by 11.8% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange…
zacks.com 5 Dividend Growth Stocks to Buy as NVDA CEO Resignation Rattles Market NVIDIA CEO Jensen Huang's resignation and market volatility bring into the spotlight five dividend growth stocks with earnings growth potential.
zacks.com Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy? Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm…benzinga.com Argus Research Maintains Buy on Cardinal Health, Raises Price Target to $309 Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $264 to $309.
prnewswire.com Cardinal Health Board of Directors Approves Quarterly Dividend DUBLIN, Ohio, Nov. 11, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5158 per share, out of the Company's capital…
zacks.com Here's Why Cardinal Health (CAH) is a Great Momentum Stock to Buy Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
benzinga.com If You Invested $100 In Cardinal Health Stock 5 Years Ago, You Would Have This Much Today Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 30.64% on an annualized basis producing an average annual return of 40.55%. Currently, Cardinal Health has a market…benzinga.com JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $286 JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $260 to $286.
benzinga.com TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $304 TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $304.
benzinga.com RBC Capital Maintains Outperform on Cardinal Health, Raises Price Target to $295 RBC Capital analyst Ryan Halsted maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $276 to $295.
benzinga.com Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $320 Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $270 to $320.
benzinga.com Cardinal Health Sees Healthy Demand, Despite Modest Commodity Pressure Cardinal Health tops Q1 2027 estimates, and raises guidance, as robust pharma sales offset petroleum headwinds in medical distribution.
benzinga.com Nasdaq Tumbles 4.5%; Cardinal Health Shares Gain After Upbeat Q1 Earnings U.S. stocks tumbled: Nasdaq -4.5%, S&P 500 -3.3%, Dow -2.5%. Cardinal Health rose on strong results; AppLovin surged 32%, while Veracyte fell 55%.
benzinga.com Cardinal Health Q1 2027 Earnings Call Transcript Cardinal Health (NYSE:CAH) reported first-quarter financial results on Thursday. The transcript from the company’s first-quarter earnings call has been provided below.This transcript is brought to…benzinga.com Cardinal Health Q1 Adj. EPS $3.26 Beats $2.94 Estimate, Sales $67.513B Beat $66.588B Estimate Cardinal Health (NYSE:CAH) reported quarterly earnings of $3.26 per share which beat the analyst consensus estimate of $2.94 by 10.88 percent. This is a 27.84 percent increase over earnings of $2.55…
benzinga.com Cardinal Health Raises FY2027 Adj EPS Guidance from $12.40-$12.60 to $12.80-$13.00 vs $12.56 Est Cardinal Health (NYSE:CAH) raises FY2027 Adj EPS guidance from $12.40-$12.60 to $12.80-$13.00 vs $12.56 analyst estimate..
benzinga.com Top Wall Street Forecasters Revamp Cardinal Health Expectations Ahead Of Q1 Earnings Cardinal Health expects Q1 EPS of $2.94 and revenue of $66.51B. Analysts remain bullish, raising price targets up to $295.
benzinga.com Dow Jumps Over 1,500 Points After Midterms: Investor Sentiment Improves, Greed Index Moves To ‘Fear’ Zone CNN Fear & Greed rose to 27 in the Fear zone as U.S. stocks surged after Democrats won Congress; oil fell and most sectors gained.
benzinga.com Qualcomm, US Foods And 3 Stocks To Watch Heading Into Thursday Stocks in focus: Cardinal Health and US Foods report earnings; Qualcomm and Snap shares fall after results; Airbnb reports after the close.
benzinga.com Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 29.24% on an annualized basis producing an average annual return of 39.65%. Currently, Cardinal Health has a market…
benzinga.com Toyota, ConocoPhillips On Deck Thursday As Auto Demand, Oil Prices Face Test Toyota Motor headlines Thursday’s reports, with investors weighing the automaker’s earnings outlook against a stock still well below its 52-week high. ConocoPhillips, Sony Group, Parker Hannifin and…benzinga.com Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $286 Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $265 to $286.
benzinga.com Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280 Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.
note.com US Stocks Summary November 17: Tech Stocks Retreat, Stock Indices Fall *Memorandum* The S&P 500 Index (SPY) fell 1.03%, the Dow Jones Industrial Average (DIA) fell 1.64%, and the Nasdaq 100 Index (QQQ) fell ...
finance.biggo.com Harbour BioMed Partner Spruce Spins Off CRHX-101 Into New Company Adrenyx, Targeting Nasdaq Listing in First Half of 2027 Harbour BioMed's partner Spruce Biosciences has spun off the CRHX-101 program into newly formed subsidiary Adrenyx Biosciences, which is expected ...
ainvest.com Aberdeen Slashes Holdings by 95% to Bet on Apple and Microsoft Aberdeen Wealth Management slashed holdings by 95% to 183, boosting portfolio value 22.26% to $254.7M via heavy bets on tech ...
quiverquant.com New Analyst Forecast: $CAH Given $320 Price Target Multiple analysts have issued price targets for $CAH recently. We have seen 13 analysts offer price targets for $CAH in the ...
247wallst.com Clover Health (CLOV) Stock Falls 8.6% Today An 8.6% slide to $4.31 came alongside declines across managed care: Humana fell 8.46%, Elevance 6.27% and CVS 3.19% in the ...
finance.yahoo.com Cardinal Health (CAH) Is Facing Multiple Class I Medical Kit Recalls Cardinal Health (NYSE:CAH) is facing multiple ongoing Class I recalls of Presource PBDS kits that contain BD Alaris Pump ...
247wallst.com UnitedHealth Group Drops 10.7% With No Clear Catalyst A 10.7% intraday drop to $344.98 hit the largest managed-care name, and rival CVS Health fell 4.61% in the same session. No catalyst is established in the available evidence.
grafa.com Harbour BioMed partner plans $50 million Adrenyx funding Harbour BioMed's partner Spruce separated CRHX-101 into Adrenyx, which secured $5 million in initial funding and plans a ...
finance.yahoo.com Harbour BioMed's Partner Spruce Biosciences Separates CRHX-101 Program into Adrenyx Biosciences, Advancing Development of Harbour BioMed-Originated Antib… Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of ...
finance.yahoo.com Is UnitedHealth Group (UNH) Stock Outpacing Its Medical Peers This Year? Here is how UnitedHealth Group (UNH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this ...
247wallst.com 4 High-Yield Healthcare Stocks Retirees Should Buy for December Income Healthcare demand holds up when the economy slows, which makes the sector a natural place for retirees to look for income ...
msn.com Stocks mixed as Nvidia erases overnight gains The S&P 500 Index ($SPX) (SPY) is down -0.20% today, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.96%, and the ...
fool.com Eli Lilly vs. Novo Nordisk: Which GLP-1 Stock Is a Better Buy for 2027? Lilly's revenue growth is turbocharged by its weight-loss pipeline, while Novo's global footprint and far lower valuation ...
msn.com Stock indexes finish lower as tech stocks retreat The S&P 500 Index ($SPX) (SPY) closed down -1.03% on Tuesday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -1.64%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.72%. December ...
ad-hoc-news.de Cardinal Health stock faces Class I recall for infusion kits The FDA classified the action as Class I, its most serious recall category. The affected Presource kits contain BD Alaris ...
rttnews.com Harbour BioMed Says Spruce Spins Out CRHX-101 Into Adrenyx Biosciences; Spruce Shares Fall Harbour BioMed Holdings Ltd. (2142.HK), a biopharmaceutical company, announced that its partner, Spruce Biosciences (SPRB), has separated its CRHX-101 (formerly SPR-202 and HBM9013) program into ...
msn.com Is Nuveen ESG Mid-Cap Value ETF (NUMV) a strong ETF right now? The Nuveen ESG Mid-Cap Value ETF (NUMV) made its debut on 12/13/2016, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - Mid Cap Value category of the market.
247wallst.com Cybersecurity stocks surge at the close: SentinelOne up 10.8% as Palo Alto earnings lift the sector Cybersecurity took the close, with SentinelOne up 10.8% and CrowdStrike and Palo Alto Networks both above 8%, the latter ...
seekingalpha.com Vertex Pharmaceuticals Incorporated (VRTX) Presents at Jefferies Global Healthcare Conference 2026 Transcript Vertex Pharmaceuticals Incorporated ( VRTX) Jefferies Global Healthcare Conference 2026 November 17, 2026 12:00 PM EST ...
msn.com Is Nuveen ESG Mid-Cap Value ETF (NUMV) a strong ETF right now? The Nuveen ESG Mid-Cap Value ETF (NUMV) made its debut on 12/13/2016, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - Mid Cap Value category of the market.
msn.com Why Cardinal Health (CAH) is a top value stock for the long-term For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
cnbc.com A generational flight from tech to defensive stocks is underway. How we’re capitalizing According to Morgan Stanley's derivatives group, the fourth quarter so far has seen the biggest rotation into defensive names ...
theglobeandmail.com Eli Lilly vs. Novo Nordisk: Which GLP-1 Stock Is a Better Buy for 2027? The global demand for next-generation metabolic treatments has sparked a fierce competition, forcing retail investors to decide between Eli Lilly & Co. (NYSE:LLY) and Novo Nordisk ...
